CATALOGO DEI PRODOTTI DELLA RICERCA

LANZAFAME, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.733
EU - Europa 2.986
AS - Asia 2.114
SA - Sud America 309
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 70
OC - Oceania 7
Totale 9.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.592
RU - Federazione Russa 1.156
SG - Singapore 872
CN - Cina 601
GB - Regno Unito 530
IT - Italia 289
BR - Brasile 253
SE - Svezia 195
VN - Vietnam 185
DE - Germania 176
IE - Irlanda 161
HK - Hong Kong 153
FR - Francia 151
FI - Finlandia 131
KR - Corea 66
CA - Canada 62
BD - Bangladesh 46
UA - Ucraina 43
IN - India 36
JP - Giappone 35
AR - Argentina 26
ZA - Sudafrica 26
MX - Messico 24
NL - Olanda 24
PL - Polonia 24
CZ - Repubblica Ceca 21
TR - Turchia 20
ID - Indonesia 19
IQ - Iraq 15
NG - Nigeria 15
BE - Belgio 14
CR - Costa Rica 13
ES - Italia 12
CO - Colombia 11
AT - Austria 10
PH - Filippine 10
CW - ???statistics.table.value.countryCode.CW??? 9
BF - Burkina Faso 8
UZ - Uzbekistan 8
IL - Israele 7
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 7
SV - El Salvador 7
CL - Cile 6
GT - Guatemala 6
RO - Romania 6
AU - Australia 5
HN - Honduras 5
JM - Giamaica 5
NI - Nicaragua 5
CH - Svizzera 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
EG - Egitto 4
GR - Grecia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
HR - Croazia 3
HU - Ungheria 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
BG - Bulgaria 1
BJ - Benin 1
CD - Congo 1
DZ - Algeria 1
GP - Guadalupe 1
GY - Guiana 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 9.222
Salva come PNG Salva come JPEG
Città #
Singapore 492
Southend 416
Moscow 410
Ashburn 391
Chandler 389
San Jose 350
Jacksonville 245
Woodbridge 234
Dallas 201
Dublin 160
Hong Kong 151
Ann Arbor 140
Council Bluffs 128
Beijing 122
Verona 94
New York 81
Los Angeles 77
The Dalles 72
Ho Chi Minh City 59
Lawrence 53
Princeton 53
Helsinki 48
Houston 47
Jinan 45
Munich 45
Nanjing 44
Shenyang 43
Wilmington 43
Santa Clara 42
Hanoi 37
Tokyo 32
São Paulo 30
Buffalo 26
Warsaw 24
Montreal 23
Hebei 21
Atlanta 20
Bologna 20
Denver 20
London 20
Orem 20
Turku 20
Frankfurt am Main 19
Tianjin 19
Toronto 19
Brno 18
Phoenix 17
Boardman 16
Redondo Beach 16
Seoul 16
Ningbo 15
Zhengzhou 15
Abuja 14
Brussels 14
Haikou 14
Johannesburg 14
Milan 14
Bloomsbury 13
Chicago 13
Sindelfingen 13
Amsterdam 12
Changsha 12
Seattle 12
Chennai 11
Guangzhou 11
Hangzhou 11
Nanchang 11
San Francisco 11
Taizhou 11
Boston 10
Brooklyn 10
Columbus 10
Jiaxing 10
Norwalk 10
Redmond 10
Stockholm 10
Jakarta 9
Redwood City 9
Rio de Janeiro 9
Willemstad 9
Da Nang 8
Dong Ket 8
Fuzhou 8
Haiphong 8
Ouagadougou 8
Rome 8
San José 8
Baghdad 7
Clearwater 7
Lanzhou 7
Manchester 7
Nuremberg 7
Poplar 7
Tashkent 7
Turin 7
Belo Horizonte 6
City of London 6
Falls Church 6
Mexico City 6
Mumbai 6
Totale 5.617
Salva come PNG Salva come JPEG
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 265
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 256
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 235
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 230
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 224
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 223
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 208
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 199
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 196
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 196
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 194
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 193
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 193
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 187
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 186
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 184
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 183
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 182
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 182
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 180
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 178
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 178
No improvement of lipodystrophy syndrome in an HIV-infected patient. 175
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 174
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 173
Can we really identify HIV-1 long-term nonprogressors? 171
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 170
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 168
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 168
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 164
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 163
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 157
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 154
Antiretroviral therapy in low-resource settings 154
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 153
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 152
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 151
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 149
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 143
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 142
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 140
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 139
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 139
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 139
The treatment of latent TB infection in HIV-positive people: the Verona experience 138
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 137
Inflammatory pseudotumor of lymph nodes. 135
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 130
Raltegravir: is a 400 mg once-daily dose enough? 130
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 124
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 114
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 112
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 93
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 92
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 92
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs-Experience From Northern Italy 49
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 46
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 41
Totale 9.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.698
article - articoli 31.245
book - libri 0
conference - conferenze 453
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022290 0 0 0 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024486 26 45 52 39 63 84 6 26 6 28 63 48
2024/20251.148 59 81 37 175 59 27 66 39 184 71 105 245
2025/20263.765 256 200 188 637 1.038 258 312 165 341 230 60 80
2026/2027606 46 82 121 357 0 0 0 0 0 0 0 0
Totale 9.323